Isatuximab as monotherapy and combined with dexamethasone in patients with relapsed/refractory multiple myeloma.
Dimopoulos M, Bringhen S, Anttila P, Capra M, Cavo M, Cole C, Gasparetto C, Hungria V, Jenner M, Vorobyev V, Ruiz EY, Yin JY, Saleem R, Hellet M, Macé S, Paiva B, Vij R.
Dimopoulos M, et al. Among authors: yin jy.
Blood. 2021 Mar 4;137(9):1154-1165. doi: 10.1182/blood.2020008209.
Blood. 2021.
PMID: 33080623
Free PMC article.
Clinical Trial.